Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Neoplasms of the CNS

Free Subscription 15.06.2020 1 Acta Neuropathol 1 AJNR Am J Neuroradiol 1 Childs Nerv Syst 2 Clin Cancer Res 2 Eur J Cancer 1 J Clin Oncol 10 J Neurooncol 3 J Neurosurg 5 Neuro Oncol 1 Neurology 1 Neuroradiology 3 Neurosurgery 2 Oncogene 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. SMITH KS, Xu K, Mercer KS, Boop F, et al
   Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource.
   Acta Neuropathol. 2020 Jun 10. pii: 10.1007/s00401-020-02171.
   PubMed         Abstract available
   
   

   
   AJNR Am J Neuroradiol

2. BARAJAS RF JR, Schwrtz D, McConnell HL, Kersch CN, et al
   Distinguishing Extravascular from Intravascular Ferumoxytol Pools within the Brain: Proof of Concept in Patients with Treated Glioblastoma.
   AJNR Am J Neuroradiol. 2020 Jun 11. pii: ajnr.A6600. doi: 10.3174/ajnr.A6600.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

3. SHOFTY B, Ben Sira L, Constantini S
   Neurofibromatosis 1-associated optic pathway gliomas.
   Childs Nerv Syst. 2020 Jun 11. pii: 10.1007/s00381-020-04697.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

4. KHASRAW M, Reardon DA, Weller M, Sampson JH, et al
   PD-1 inhibitors: Do they have a future in the treatment of glioblastoma?
   Clin Cancer Res. 2020 Jun 11. pii: 1078-0432.CCR-20-1135.
   PubMed         Abstract available
   
   
5. INDRACCOLO S, De Salvo GL, Verza M, Caccese M, et al
   Phosphorylated Acetyl-CoA Carboxylase is associated with clinical benefit with Regorafenib in relapsed glioblastoma: REGOMA Trial Biomarker Analysis.
   Clin Cancer Res. 2020 Jun 9. pii: 1078-0432.CCR-19-4055.
   PubMed         Abstract available
   
   

   
   Eur J Cancer

6. LLUCH A, Gonzalez-Angulo AM, Casadevall D, Eterovic AK, et al
   Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.
   Eur J Cancer. 2019;120:54-64.
   PubMed         Abstract available
   
   
7. CHANG LC, Lim CK, Chang LY, Chen KY, et al
   Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors.
   Eur J Cancer. 2019;119:77-86.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

8. MELLINGHOFF IK, Ellingson BM, Touat M, Maher E, et al
   Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma.
   J Clin Oncol. 2020 Jun 12:JCO1903327. doi: 10.1200/JCO.19.03327.
   PubMed         Abstract available
   
   

   
   J Neurooncol

9. LIN AJ, Kane LT, Molitoris JK, Smith DR, et al
   A multi-institutional analysis of clinical outcomes and patterns of care of 1p/19q codeleted oligodendrogliomas treated with adjuvant or salvage radiation therapy.
   J Neurooncol. 2020;146:121-130.
   PubMed         Abstract available
   
   
10. NISHIMOTO M, Ohara K, Kamamoto D, Tamura R, et al
    Tumor immune microenvironment is associated with the growth of intracranial germinomas.
    J Neurooncol. 2020;146:139-146.
    PubMed         Abstract available
    
    
11. YOUNGERMAN BE, Joiner EF, Wang X, Yang J, et al
    Patterns of seizure prophylaxis after oncologic neurosurgery.
    J Neurooncol. 2020;146:171-180.
    PubMed         Abstract available
    
    
12. PRADA F, Sheybani N, Franzini A, Moore D, et al
    Fluorescein-mediated sonodynamic therapy in a rat glioma model.
    J Neurooncol. 2020 Jun 4. pii: 10.1007/s11060-020-03536.
    PubMed         Abstract available
    
    
13. SUN Y, Bailey CP, Sadighi Z, Zaky W, et al
    Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities.
    J Neurooncol. 2020 Jun 5. pii: 10.1007/s11060-020-03546.
    PubMed         Abstract available
    
    
14. LIU B, Liu S, Wang Y, Lu D, et al
    Impact of neurosurgical enhanced recovery after surgery (ERAS) program on health-related quality of life in glioma patients: a secondary analysis of a randomized controlled trial.
    J Neurooncol. 2020 Jun 6. pii: 10.1007/s11060-020-03548.
    PubMed         Abstract available
    
    
15. NELLAN A, Wright E, Campbell K, Davies KD, et al
    Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.
    J Neurooncol. 2020 Jun 6. pii: 10.1007/s11060-020-03549.
    PubMed         Abstract available
    
    
16. COHEN AL, Anker CJ, Johnson B, Burt LM, et al
    Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial.
    J Neurooncol. 2020 Jun 6. pii: 10.1007/s11060-020-03551.
    PubMed         Abstract available
    
    
17. BARON RB, Lakomkin N, Schupper AJ, Nistal D, et al
    Postoperative outcomes following glioblastoma resection using a robot-assisted digital surgical exoscope: a case series.
    J Neurooncol. 2020 Jun 9. pii: 10.1007/s11060-020-03543.
    PubMed         Abstract available
    
    
18. LI Y, Lu D, Feng D, Cheng H, et al
    Management of incidental anterior skull base large and giant meningiomas in elderly patients.
    J Neurooncol. 2020 Jun 11. pii: 10.1007/s11060-020-03484.
    PubMed         Abstract available
    
    

    
    J Neurosurg

19. KONG DS, Kim YH, Hong CK
    Optimal indications and limitations of endoscopic transorbital superior eyelid surgery for spheno-orbital meningiomas.
    J Neurosurg. 2020 Jun 5:1-8. doi: 10.3171/2020.3.JNS20297.
    PubMed         Abstract available
    
    
20. GARTON ALA, Kinslow CJ, Wang TJC
    Erratum. Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    J Neurosurg. 2020 Jun 5:1. doi: 10.3171/2020.5.JNS192767.
    PubMed        
    
    
21. GOGOS AJ, Young JS, Morshed RA, Avalos LN, et al
    Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways.
    J Neurosurg. 2020 Jun 5:1-10. doi: 10.3171/2020.3.JNS193434.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

22. EATON BR, Yock TI
    Radiation for Pediatric Low Grade Gliomas: who will benefit and how late is soon enough?
    Neuro Oncol. 2020 Jun 9. pii: 5855151. doi: 10.1093.
    PubMed        
    
    
23. BOXERMAN JL, Quarles CC, Hu LS, Erickson BJ, et al
    Consensus Recommendations for a Dynamic Susceptibility Contrast MRI Protocol for Use in High-Grade Gliomas.
    Neuro Oncol. 2020 Jun 9. pii: 5855183. doi: 10.1093.
    PubMed         Abstract available
    
    
24. LEACH JL, Roebker J, Schafer A, Baugh J, et al
    MR Imaging features of Diffuse Intrinsic Pontine Glioma (DIPG) and Relationship to Overall Survival: Report from the International DIPG Registry.
    Neuro Oncol. 2020 Jun 6. pii: 5854320. doi: 10.1093.
    PubMed         Abstract available
    
    
25. GROSSMAN SA, Romo CG, Rudek MA, Supko J, et al
    Baseline Requirements for Novel Agents Being Considered for Phase II/III Brain Cancer Efficacy Trials:Conclusions from the Adult Brain Tumor Consortium's First Workshop on CNS Drug Delivery.
    Neuro Oncol. 2020 Jun 7. pii: 5854364. doi: 10.1093.
    PubMed        
    
    
26. JARAIZ-RODRIGUEZ M, Talaveron R, Garcia-Vicente L, Pelaz SG, et al
    Erratum to 'Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo'.
    Neuro Oncol. 2020 Jun 9. pii: 5854970. doi: 10.1093.
    PubMed        
    
    

    
    Neurology

27. BRODSKY MC, Fairbanks AM, Daniels DJ
    Surgical treatment of chiasmal glioma in neurofibromatosis 1.
    Neurology. 2020 Jun 11. pii: WNL.0000000000009732.
    PubMed        
    
    

    
    Neuroradiology

28. WINDISCH P, Weber P, Furweger C, Ehret F, et al
    Implementation of model explainability for a basic brain tumor detection using convolutional neural networks on MRI slices.
    Neuroradiology. 2020 Jun 4. pii: 10.1007/s00234-020-02465.
    PubMed         Abstract available
    
    

    
    Neurosurgery

29. MILLESI M, Widhalm G
    In Reply: Is Intraoperative Pathology Needed if 5-Aminolevulinic-Acid-Induced Tissue Fluorescence Is Found in Stereotactic Brain Tumor Biopsy?
    Neurosurgery. 2020 Jun 5. pii: 5854027. doi: 10.1093.
    PubMed        
    
    
30. ALEXIOU GA, Vartholomatos G, Goussia A, Voulgaris S, et al
    Letter: Is Intraoperative Pathology Needed if 5-Aminolevulinic-Acid-Induced Tissue Fluorescence Is Found in Stereotactic Brain Tumor Biopsy?
    Neurosurgery. 2020 Jun 5. pii: 5854026. doi: 10.1093.
    PubMed        
    
    
31. NOLL KR
    Commentary: Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.
    Neurosurgery. 2020 Jun 8. pii: 5854690. doi: 10.1093.
    PubMed        
    
    

    
    Oncogene

32. YU S, Yu X, Sun L, Zheng Y, et al
    GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway.
    Oncogene. 2020 Jun 9. pii: 10.1038/s41388-020-1348.
    PubMed         Abstract available
    
    
33. AWAH CU, Chen L, Bansal M, Mahajan A, et al
    Ribosomal protein S11 influences glioma response to TOP2 poisons.
    Oncogene. 2020 Jun 11. pii: 10.1038/s41388-020-1342.
    PubMed         Abstract available
    
    

    
    PLoS One

34. TAKASHIMA Y, Kawaguchi A, Iwadate Y, Hondoh H, et al
    miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
    PLoS One. 2020;15:e0229577.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: